Paul Newhouse

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read More

Mikail Rubinov, assistant professor of biomedical engineering, computer science, psychiatry and psychology, has been awarded a four-year, $1.1 million grant from the National Institute of Mental Health to better understand the development and organization of brain networks, as well as their change in development and aging. Read More

Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report. Read More

The Vanderbilt Kennedy Center and the Down Syndrome Association of Middle Tennessee will co-sponsor a webinar, “Risks of Alzheimer's Disease in Adults with Down Syndrome and Introduction to a Research Study,” on Monday, March 29, from 7 to 8 p.m. CT. Read More

VU319, an investigational drug product developed by Vanderbilt researchers, targets one of medicine’s most bedeviling challenges: improving memory loss in people with Alzheimer’s disease. Read More

Prestigious grant awarded to Nilanjan Sarkar, Vanderbilt researcher developing social robotics to stymie apathy among older adults. Read More

Three years ago Reece Dean, of Nashville’s Bellevue community, retired at age 69 from a career as a busy truck driver. Mary Ann, his wife, began to notice some changes in his memory and behavior since he was home more consistently. Read More

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects. Read More

Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains. Read More

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center. Read More

Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease. Read More

The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women. Read More

Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read More

Nine Vanderbilt faculty members named to endowed chairs were recognized for outstanding academic achievement during a Dec. 12 ceremony. (Photo by Steve Green) Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements last week during a celebration at the Student Life… Read More

Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements Dec. 12 during a celebration at the Student Life Center. Read More

Paul Newhouse, Jim Turner Professor of Cognitive Disorders, is interviewed about his research showing that nicotine can help boost memory in people with mild cognitive impairment. Read More

This Week on VUCast, Vanderbilt’s weekly newscast  highlighting  research, experts, students, sports and everything Vanderbilt: ·         Inside A Preds coach’s deep brain stimulation surgery ·         How nicotine could impact memory ·         Why a research lab wants Vandy undergrads [vucastblurb]… Read More

Wearing a nicotine patch may help improve memory loss in older adults with mild cognitive impairment, according to a study published this week by Paul Newhouse, director of the Center for Cognitive Medicine. Read More

Short-term hormone replacement therapy offers potential benefit for cognitive functioning. Read More